MACTER Stock Overview
A contract manufacturer, manufactures and markets pharmaceutical products and formulations for healthcare companies in Pakistan.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
Macter International Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | PK₨91.00 |
52 Week High | PK₨106.30 |
52 Week Low | PK₨75.75 |
Beta | 0 |
1 Month Change | 6.31% |
3 Month Change | -11.64% |
1 Year Change | -13.25% |
3 Year Change | -31.53% |
5 Year Change | 43.99% |
Change since IPO | 5.72% |
Recent News & Updates
Recent updates
Shareholder Returns
MACTER | PK Life Sciences | PK Market | |
---|---|---|---|
7D | 4.6% | -3.1% | -0.6% |
1Y | -13.3% | -28.4% | 60.0% |
Return vs Industry: MACTER exceeded the PK Life Sciences industry which returned -28.4% over the past year.
Return vs Market: MACTER underperformed the PK Market which returned 60% over the past year.
Price Volatility
MACTER volatility | |
---|---|
MACTER Average Weekly Movement | n/a |
Life Sciences Industry Average Movement | 6.5% |
Market Average Movement | 5.2% |
10% most volatile stocks in PK Market | 7.8% |
10% least volatile stocks in PK Market | 3.2% |
Stable Share Price: MACTER has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MACTER's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1992 | n/a | Asif Misbah | www.macter.com |
Macter International Limited, a contract manufacturer, manufactures and markets pharmaceutical products and formulations for healthcare companies in Pakistan. It provides pharmaceutical products in the areas of antibiotics, anti-allergy, cardiovascular, anti-viral, etc.; and consumer and biological products. The company offers solid and liquid oral dosage forms, such as tablets, capsules, syrups, suspensions, and dry powders; injections, including sterile liquid vials, sterile liquid ampoules, and sterile dry powders; and ointments and creams, drops, and inhalers.
Macter International Limited Fundamentals Summary
MACTER fundamental statistics | |
---|---|
Market cap | PK₨4.17b |
Earnings (TTM) | PK₨0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs MACTER overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MACTER income statement (TTM) | |
---|---|
Revenue | PK₨0 |
Cost of Revenue | PK₨0 |
Gross Profit | PK₨0 |
Other Expenses | PK₨0 |
Earnings | PK₨0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did MACTER perform over the long term?
See historical performance and comparison